Clinical isolates of Streptococcus mitis/oralis-related species with reduced carbapenem susceptibility, harboring amino acid substitutions in penicillin-binding proteins in JapanANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52024-04-031OA
Hydroxyhexylitaconic acids as potent IMP-type metallo-β-lactamase inhibitors for controlling carbapenem resistance in EnterobacteralesMICROBIOLOGY SPECTRUMIF3.82024-03-050OAAI
Difference in the Inhibitory Effect of Thiol Compounds and Demetallation Rates from the Zn(II) Active Site of Metallo-β-lactamases (IMP-1 and IMP-6) Associated with a Single Amino Acid SubstitutionACS INFECTIOUS DISEASESIF3.82022-12-152PRE
Isolation of Group A Streptococci with Reduced In Vitro β-Lactam Susceptibility Harboring Amino Acid Substitutions in Penicillin-Binding Proteins in Japan日本青霉素结合蛋白中具有氨基酸取代的体外 β-内酰胺敏感性降低的A组链球菌的隔离ANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52021-11-177OA
Practical Agar-Based Disk Diffusion Tests Using Sulfamoyl Heteroarylcarboxylic Acids for Identification of Subclass B1 Metallo-β-Lactamase-Producing EnterobacteralesJOURNAL OF CLINICAL MICROBIOLOGYIF5.42021-09-200OA
Crystal Structures of Metallo-β-Lactamase (IMP-1) and Its D120E Mutant in Complexes with Citrate and the Inhibitory Effect of the Benzyl Group in Citrate Monobenzyl EsterJOURNAL OF MEDICINAL CHEMISTRYIF6.82021-07-097PREAI
Sulfamoyl Heteroarylcarboxylic Acids as Promising Metallo-β-Lactamase Inhibitors for Controlling Bacterial Carbapenem ResistanceMBIOIF4.72020-04-2834OAAI
4-Amino-2-Sulfanylbenzoic Acid as a Potent Subclass B3 Metallo-β-Lactamase-Specific Inhibitor Applicable for Distinguishing Metallo-β-Lactamase SubclassesANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52019-10-0111OAAI
Intercellular Transfer of Chromosomal Antimicrobial Resistance Genes between Acinetobacter baumannii Strains Mediated by ProphagesANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52019-08-0145OAAI
Isolation of group B Streptococcus with reduced β-lactam susceptibility from pregnant womenEMERGING MICROBES & INFECTIONSIF7.52019-01-1632OAAI
Relatively high rates of cefotaxime- and ceftriaxone-non-susceptible isolates among group B streptococci with reduced penicillin susceptibility (PRGBS) in JapanJOURNAL OF ANTIMICROBIAL CHEMOTHERAPYIF3.62019-01-1113PREAI
High isolation rate and multidrug resistance tendency of penicillin-susceptible group B Streptococcus with reduced ceftibuten susceptibility in JapanEUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASESIF32018-05-1713PREAI
Structural Insights into the TLA-3 Extended-Spectrum β-Lactamase and Its Inhibition by Avibactarn and OP0595ANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52017-10-0111OAAI
High rate of slowly-killed-by-ampicillin phenotype among group B streptococci with reduced penicillin susceptibilityJOURNAL OF ANTIMICROBIAL CHEMOTHERAPYIF3.62016-12-201OAAI
A Highly Macrolide-Resistant Campylobacter jejuni Strain with Rare A2074T Mutations in 23S rRNA GenesANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52016-04-0112OAAI
High isolation rate of MDR group B streptococci with reduced penicillin susceptibility in JapanJOURNAL OF ANTIMICROBIAL CHEMOTHERAPYIF3.62015-07-1378OAAI
New plasmid-mediated aminoglycoside 6′-N-acetyltransferase, AAC(6′)-Ian, and ESBL, TLA-3, from a Serratia marcescens clinical isolateJOURNAL OF ANTIMICROBIAL CHEMOTHERAPYIF3.62015-01-0823OAAI
Have group A streptococci with reduced penicillin susceptibility emerged?JOURNAL OF ANTIMICROBIAL CHEMOTHERAPYIF3.62014-12-036OAAI
Evaluation of Disk Potentiation Test Using Kirby-Bauer Disks Containing High-Dosage Fosfomycin and Glucose-6-Phosphate To Detect Production of Glutathione S-Transferase Responsible for Fosfomycin ResistanceJOURNAL OF CLINICAL MICROBIOLOGYIF5.42014-10-012OAAI
Practical Agar-Based Disk Potentiation Test for Detection of Fosfomycin-Nonsusceptible Escherichia coli Clinical Isolates Producing Glutathione S-TransferasesJOURNAL OF CLINICAL MICROBIOLOGYIF5.42014-09-0149OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向